Nyman JA. The economics of moral hazard revisited. Journal of Health Economics. 1999. 18: 811-82. B, Gafni A. When do the dollars make sense? Towards a conceptual O’Brien framework for contingent valuation studies. 1996. 16: Medical Decision Making. 288–99. B, Viramontes JL. Willingness to pay: a valid and reliable measure of health O’Brien state preferences? 1994. 14; 3: 289-97. Medical Decision Making. Office for National Statistics. Measuring Subjective Well-being. Office for National 2011. Statistics. Olsen JA, Smith RD. Theory versus practice: a review of in “willingness-to-pay” health and health care. 2001. 10; 1: 39–52. Health Economics. Papaioannou D, Brazier J, Parry G. How to measure quality of life for cost effectiveness analysis in personality disorder? A systematic review. HEDS 2013. discussion paper 13/02. Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. 2011. 14; 6: 907-20. Value Health. Parducci A. Contextual effects. A range-frequency analysis. In: Carterette E, Friedman M. Handbook of perception. vol 2. 1974. Academic Press: New York. Parkin D, Devlin N. Is there a case for using visual analogue scale valuations in cost utility analysis?. 2006. 15: 653-64. Health Economics. Parliamentary Well-being group. 2014. Available from: Parsons T. Definitions of health and illness in light of American values and social structure. in Gartley Jaco E. Patients, Physicians, and Illness. New York: The Free Press. 1958.
Nyman JA. The economics of moral hazard revisited. Journal of Health Economics. 1999. 18: 811-82. O’Brien B, Gafni A. When do the dollars make sense? Towards a conceptual framework for contingent valuation studies. Medical Decision Making. 1996. 16: 288–99. O’Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preferences? Medical Decision Making. 1994. 14; 3: 289-97. Office for National Statistics. Measuring Subjective Well-being. Office for National Statistics. 2011. Olsen JA, Smith RD. Theory versus practice: a review of “willingness-to-pay” in health and health care. Health Economics. 2001. 10; 1: 39–52. Papaioannou D, Brazier J, Parry G. How to measure quality of life for cost effectiveness analysis in personality disorder? A systematic review. HEDS discussion paper 13/02. 2013. Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. Value Health. 2011. 14; 6: 907-20. Parducci A. Contextual effects. A range-frequency analysis. In: Carterette E, Friedman M. Handbook of perception. vol 2. Academic Press: New York. 1974. Parkin D, Devlin N. Is there a case for using visual analogue scale valuations in cost utility analysis?. Health Economics. 2006. 15: 653-64. Parliamentary Well-being group. 2014. Available from: Parsons T. Definitions of health and illness in light of American values and social structure. in Gartley Jaco E. Patients, Physicians, and Illness. New York: The Free Press. 1958.
PhD%20thesis%20FINAL_after%20VIVA_SUBMITED.docx